Psychiatric News (2/17) reports a study found that “individuals with severe alcohol-related liver disease (ALD) who take alcohol use disorder (AUD) medications have higher survival rates over three years.” The researchers “assessed the survival rates of 1,309 patients (76% male) with severe ALD who were referred to a tertiary medical center for a liver transplant evaluation.” They observed that “individuals who used AUD medications for at least three months had a 6.6% higher one-year survival rate and an 18.5% higher three-year survival rate compared with those who used AUD medications for three months or less.” They also noted that “as medication duration increased, mortality decreased: Just 12.6% of patients with more than six months of AUD medication use died during follow-up, compared with 34.7% of those with no medication use.” The study was published in JAMA Network Open.
Related Links:
— “AUD Medications May Improve Survival in Patients With Severe Liver Disease, Psychiatric News, February 17, 2026